Fifty-seventh annual meeting of the American association of physicists in medicine
SU-E-J-239: Influence of RF Coil Materials On Surface and Buildup Dose From a 6MV Photon Beam
In order to perform real time tumour tracking using an integrated Linac-MR, images have to be acquired during irradiation. MRI uses RF coils in close proximity to the imaged volume. Given current RF coil designs this means that the high energy photons will be passing through the coil before reaching the patient. This study experimentally investigates the dose modifications that occur due to the presence of various RF coil materials in the treatment beam.
Polycarbonate, copper or aluminum tape, and Teflon were used to emulate the base, conductor and cover respectively of a surface RF coil. These materials were placed at various distances from the surface of polystyrene or solid water phantoms which were irradiated in the presence of no magnetic field, a transverse 0.2T magnetic field, and a parallel 0.2T magnetic field. Percent depth doses were measured using ion chambers.
A significant increase in surface and buildup dose is observed. The surface dose is seen to decrease with an increasing separation between the emulated coil and the phantom surface, when no magnetic field is present. When a transverse magnetic field is applied the surface dose decreases faster with increasing separation, as some of the electrons created in the coil are curved away from the phantom's surface. When a parallel field is present the surface dose stays approximately constant for small separations, only slightly decreasing for separations greater than 5cm, since the magnetic field focuses the electrons produced in the coil materials not allowing them to scatter.
Irradiating a patient through an RF coil leads to an increase in the surface and buildup doses. Mitigating this increase is important for the successful clinical use of either a transverse or a parallel configuration Linac-MR unit.
This project is partially supported by an operating grant from the Canadian Institute of Health Research (CIHR MOP 93752)